S. Kanasaki

Ephrin receptor A10 is a promising drug target potentially useful for breast cancers including triple negative breast cancers.

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Annexin A4 is a possible biomarker for cisplatin susceptibility of malignant mesothelioma cells.

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2012, Biochemical and biophysical research communications.

Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis.

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2013, Die Pharmazie.

Ephrin type-A receptor 2 on tumor-derived exosomes enhances angiogenesis through the activation of MAPK signaling.

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2019, Die Pharmazie.

Expression of Eph receptor A10 is correlated with lymph node metastasis and stage progression in breast cancer patients

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2013, Cancer medicine.

Ephrin receptor A10 is a promising drug target potentially useful for breast cancers including triple negative breast cancers.

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2014, Journal of controlled release : official journal of the Controlled Release Society.